skip to Main Content
Toronto Medical Cannabis Dispensaries Reeling After Police Raids

Mitchell Cutler had just finished selling a THC-infused ointment to an arthritic woman — her “medicine” — when Toronto police showed up and charged him with possession for the purposes of trafficking.

“If these charges do stick I guess my future is pretty much over,” said the marijuana dispensary worker, who says he has never before been in trouble with police.

Cutler was at city hall Monday as part of a coalition of pot dispensaries urging the city to drop the charges laid by Toronto police during raids last Thursday.

Police and city municipal licensing officials targeted 43 locations last week, where 90 people were arrested. In all, 186 possession for the purpose of trafficking charges and 71 proceeds of crime charges were laid. Bylaw officers also laid 79 charges of zoning violations.

Even so, there was still pot being sold Monday in at least one storefront operation in Toronto. [Read more at the Toronto Star]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

POSaBIT Buys Suite of Platforms (Leaf Data Systems, MJ Platform and Ample Organics) from Embattled Akerna Corp.

POSaBIT, the cannabis point-of-sale (POS) and payments software company, this morning announced its planned acquisition of  MJ Platform (MJ Freeway), Leaf Data Systems, and Ample Organics from embattled software company…

New York State now has 66 licensed cannabis retailers

New York marijuana regulators on Wednesday approved dozens of conditional adult-use dispensary licenses in a session during which members also discussed adopting bylaws for how the board runs meetings and makes decisions.…

FDA Says “No” to CBD Foods and Dietary Supplements

By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA…

FDA finalizes guidance on cannabis clinical research

The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without…

More Categories

Back To Top
×Close search